IL23A and psoriasis: Many other inflammation-related diseases, such as multiple sclerosis, psoriasis, rheumatoid arthritis, inflammatory bowel disease, and asthma [5,11,12], have been characterized as having significant dysfunctions in the interleukin (IL)-23/IL-17 signaling pathway.